On Demand Webinars

1. Intelligent mRNA Manufacturing Through Process Analytical Technologies 3/10/2025

   Learn how predictive models can monitor key CQAs, such as RNA concentration and nucleoside triphosphate consumption, and explore RBP and MIT’s vision for revolutionizing biomanufacturing.

2. RNA Vaccine Development To Phase I 4/14/2022

   Dr. John Lewis, Founder and CEO, Entos Pharmaceuticals, presents RNA Vaccine Development to Phase I.

3. Mitigating Risk With Ex-U.S. Clinical Trials 7/8/2025

   Gain insight into why certain regions offer strategic advantages, from regulatory flexibility to faster enrollment, and how to effectively integrate them into your development strategy.

4. Are You Keeping Pace With Oligo Synthesis Optimization? 11/18/2025

   The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.

5. Development And Regulatory Strategy For US And China 9/22/2022

   This webinar discusses the expansion of International Market for Ensartini and RNAi Therapeutics in Oncology, from Skin Cancers to Liver Cancers.

6. Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery 6/3/2025

   Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.

7. Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

   Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

8. Frontiers In Digital Bioprocessing 2/8/2022

   In this talk we will dive into 2 digital technologies: modular design and cloud. Both areas have the potential to accelerate the critical aspects of the facility of the future.

9. Overcoming Key Challenges In Vaccine Development 4/14/2022

   Dive into this overview of vaccine development and learn how to overcome some key challenges with Precision NanoSystems Inc.'s field application scientist, Dr. Ian Villamagna.

10. Real-Time Monitoring Of Higher-Order Structure Of RNAs 9/10/2025

    Learn how a new biophysical characterization strategy can enhance RNA therapeutic candidate screening and formulation development through a deeper understanding of RNA structure under native conditions.